Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.

Lexeo Therapeutics, a US-based gene therapy developer spun out of Cornell University, has raised $100m in a series B round co-led by asset managers D1 Capital Partners and Eventide Asset Management. The round included life sciences real estate investment trust Alexandria Real Estate Equities’ investment arm Alexandria Venture Investments and Lundbeckfonden Ventures, an evergreen fund for Lundbeckfonden, the foundation that owns pharmaceutical firm Lundbeck. Verition Fund Management, Laurion Capital Management, Longitude Capital, Gray’s Creek Capital, Omega Funds, Janus Henderson Investors, PBM Capital, Woodline Partners and Invus Capital filled out the round. Founded in 2018, Lexeo has worked to develop gene therapies to treat certain genetically-derived diseases like Alzheimer’s, Batten disease and certain cardiovascular conditions. It will use the funding to advance its pipeline, including preclinical and clinical assets. Lexeo’s $85m series A round was co-led by Longitude Capital and Omega Funds in January 2021 and included Lundbeckfonden, Alexandria Venture Investments, Alzheimer’s Drug Discovery Foundation, PBM Capital, Janus Henderson Investors, Woodline Partners and Invus Capital. R Nolan Townsend, chief executive of Lexeo, said: “As we embark on our next phase of growth, we are highly encouraged by the support of this diverse range of long-term focused investors participating in our series B financing. “With this capital infusion, we plan to advance our clinical stage pipeline to meaningful near-term data catalysts while establishing portfolio leadership positions in cardiac gene therapy and the genetics of Alzheimer’s disease.” – A version of this article first appeared on our sister site, Global Corporate Venturing.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.